Search

Your search keyword '"Neoplasm Metastasi"' showing total 218 results

Search Constraints

Start Over You searched for: Descriptor "Neoplasm Metastasi" Remove constraint Descriptor: "Neoplasm Metastasi" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
218 results on '"Neoplasm Metastasi"'

Search Results

1. Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)

2. Genomic–transcriptomic evolution in lung cancer and metastasis

3. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

4. Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer

5. Searching for novel multimodal treatments in oligometastatic pancreatic cancer

6. The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

7. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells

8. Sleeping beauty genetic screen identifies miR-23b::BTBD7 gene interaction as crucial for colorectal cancer metastasis

9. Bone vascular niche E-selectin induces mesenchymal–epithelial transition and Wnt activation in cancer cells to promote bone metastasis

10. Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study

11. Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer

12. Accurate quantification of copy-number aberrations and whole-genome duplications in multi-sample tumor sequencing data

13. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

14. Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition

15. Effect of Bevacizumab in Combination with Standard Oxaliplatin-Based Regimens in Patients with Metastatic Colorectal Cancer: A Randomized Clinical Trial

16. Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial

17. Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis

18. New development on hysteroscopy for endometrial cancer diagnosis: state of the art

19. Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors

20. Lumican inhibits in vivo melanoma metastasis by altering matrix-effectors and invadopodia markers

21. Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trials

22. The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

23. Malignancy course of pituitary adenoma in MEN1 syndrome: Clinical-Neuroradiological signs

24. Advances in paclitaxel combinations for treating cervical cancer

25. Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): Towards an in-house molecular prognostication for pathologists?

26. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?

27. Statin Use and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Abiraterone Acetate

28. Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report

29. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer

30. Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience

31. Dose escalation in extracranial stereotactic ablative radiotherapy (DESTROY-1): A multiarm Phase I trial

32. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses

33. Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma.

34. Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial

35. Lac-l-TTA, a novel lactose-based amino acid–sugar conjugate for anti-metastatic applications

36. Detection of liver metastases in cancer patients with geographic fatty infiltration of the liver: the added value of contrast-enhanced sonography

37. The Clinical Efficacy of Enzalutamide in Metastatic Prostate Cancer: Prospective Single-center Study

38. Extraskeletal osteosarcoma

39. Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis

40. Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis

41. Third- and later-line treatment in advanced or metastatic gastric cancer: a systematic review and meta-analysis

42. Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma

43. 68Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study

44. Anti-EGFR-resistant clones decay exponentially after progression: Implications for anti-EGFR re-challenge

45. Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen

46. Trastuzumab emtansine for residual invasive HER2-positive breast cancer

47. Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model

48. Microwave ablation of hepatic tumors with a third generation system: loco‑regional efficacy in a prospective cohort study with intermediate term follow-up

49. A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma: A multicenter phase I GRAN-T-MTC study

50. Treatment of advanced breast cancer with a metronomic schedule of oral vinorelbine: what is the opinion of Italian oncologists?

Catalog

Books, media, physical & digital resources